COYA, Dr. Reddys Sign Deal for Proposed Abatacept Biosimilar - Nasdaq
| APTXDelisted Stock | USD 0.07 0.01 16.67% |
Slightly above 55% of Aptinyx's investors are presently thinking to get in. The analysis of current outlook of investing in Aptinyx suggests that some traders are interested regarding Aptinyx's prospects. Aptinyx's investing sentiment can be driven by a variety of factors including economic data, Aptinyx's earnings reports, geopolitical events, and overall market trends.
Aptinyx |
COYA, Dr. Reddys Sign Deal for Proposed Abatacept Biosimilar Nasdaq
Read at news.google.com
 |
Aptinyx Fundamental Analysis
We analyze Aptinyx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aptinyx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aptinyx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Aptinyx is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Aptinyx Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aptinyx stock to make a market-neutral strategy. Peer analysis of Aptinyx could also be used in its relative valuation, which is a method of valuing Aptinyx by comparing valuation metrics with similar companies.
Peers
Aptinyx Related Equities
| RVPH | Reviva Pharmaceuticals | 8.77 | ||||
| ADTX | Aditxt | 5.71 | ||||
| ALRN | Aileron Therapeutics | 4.38 | ||||
| ATXI | Avenue Therapeutics | 4.37 | ||||
| ABVC | ABVC Biopharma | 3.92 | ||||
| CTMX | CytomX Therapeutics | 3.92 | ||||
| RNAZ | Transcode Therapeutics | 2.94 | ||||
| QNRX | Quoin Pharmaceuticals | 1.69 | ||||
| ASMB | Assembly Biosciences | 1.25 | ||||
| ADIL | Adial Pharmaceuticals | 1.01 | ||||
| ACHL | Achilles Therapeutics | 0.93 | ||||
| SPRO | Spero Therapeutics | 0.88 | ||||
| NRBO | Neurobo Pharmaceuticals | 0.43 | ||||
| NUVB | Nuvation Bio | 0.35 | ||||
| ALLR | Allarity Therapeutics | 0.90 | ||||
| VRAX | Virax Biolabs | 4.83 | ||||
| TIL | Instil Bio | 9.39 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Aptinyx Stock
If you are still planning to invest in Aptinyx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aptinyx's history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |